Joshua D. Grill | Mary Ryan Baumannhttps://maryryan.netlify.app/author/joshua-d.-grill/Joshua D. GrillWowchemy (https://wowchemy.com)en-us© Mary Ryan Baumann 2025Thu, 27 Feb 2025 00:00:00 +0000https://maryryan.netlify.app/media/icon_hu885146a88f720ebbe3814c746cadef9e_9536_512x512_fill_lanczos_center_2.pngJoshua D. Grillhttps://maryryan.netlify.app/author/joshua-d.-grill/Impact of Study Partner Replacement in Mild Cognitive Impairment Clinical Trialshttps://maryryan.netlify.app/publication/dolmadjian-sp-replacement-2025/Thu, 27 Feb 2025 00:00:00 +0000https://maryryan.netlify.app/publication/dolmadjian-sp-replacement-2025/Reasons for undergoing amyloid imaging among cognitively unimpaired older adultshttps://maryryan.netlify.app/publication/ryan-amyloidreasons-2021/Tue, 06 Jul 2021 00:00:00 +0000https://maryryan.netlify.app/publication/ryan-amyloidreasons-2021/Using Direct-to-Consumer Genetic Testing Results to Accelerate Alzheimer Disease Clinical Trial Recruitmenthttps://maryryan.netlify.app/publication/dtc-c2c-2020/Wed, 14 Oct 2020 00:00:00 +0000https://maryryan.netlify.app/publication/dtc-c2c-2020/Is Reluctance to Share Alzheimer’s Disease Biomarker Status with a Study Partner a Barrier to Preclinical Trial Recruitment?https://maryryan.netlify.app/publication/cox-biomarker-barrier-2020/Sat, 27 Jun 2020 00:00:00 +0000https://maryryan.netlify.app/publication/cox-biomarker-barrier-2020/A preliminary study of clinical trial enrollment decisions among people with Mild Cognitive Impairment and their study partnershttps://maryryan.netlify.app/publication/cox-mci-2019/Sun, 03 Nov 2019 00:00:00 +0000https://maryryan.netlify.app/publication/cox-mci-2019/Participant and Study Partner Prediction and Identification of Cognitive Impairment in Preclinical Alzheimer's Disease- Study Partner vs. Participant Accuracyhttps://maryryan.netlify.app/publication/sp-info-2019/Fri, 18 Oct 2019 00:00:00 +0000https://maryryan.netlify.app/publication/sp-info-2019/